Israel: Second Subject Completes All Experimental Treatment Sessions

On July 10, 2013, the second subject completed their last experimental treatment in our ongoing Israeli study of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD. Data collected from this study will allow comparisons between the effects of different doses of MDMA on PTSD symptoms, and on symptoms of depression and sleep quality. Led by Clinical Investigator Moshe Kotler, M.D., at Beer Yaakov Mental Hospital, this study will treat 10 subjects with chronic, treatment-resistant PTSD.